Neutrino properties and neutrino astronomy: Where do we stand, where are we going? - Experiments

被引：1
|
作者：
Spiro, M [1 ]
Lachenmaier, T
机构：
[1] CEA Saclay, DAPNIA, F-91191 Gif Sur Yvette, France
[2] Tech Univ Munich, Phys Dept E15, D-85748 Garching, Germany
来源：
NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS | 2003年 / 118卷
关键词：
D O I：
10.1016/S0920-5632(03)01340-9
中图分类号：
O412 [相对论、场论]; O572.2 [粒子物理学];
学科分类号：
摘要：
We have been witnessing during the "XXth International Conference on Neutrino Physics and Astrophysics (Neutrino 2002)" in Munich a lot of new and exciting results. Neutrino physics is blooming. This paper is only reflecting part of the richness of this expanding field.
引用
收藏
页码：413 / 424
页数：12
相关论文
共 50 条
  • [21] Squamous Cell Lung Cancer: Where Do We Stand and Where Are We Going?
    Hirsch, Fred R.
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 914 - 915
  • [22] Pulmonary hypertension and beta blockers: where do we stand? Where are we going?
    Bugan, B.
    Roach, E. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 229 - 234
  • [23] The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
    Agapidou, Alexandra
    Stavrakis, Thomas
    Vlachaki, Efthymia
    Anagnostis, Panagiotis
    Vakalopoulou, Sophia
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 88 - 93
  • [24] VERY HIGH ENERGY GAMMA ASTRONOMY: WHERE DO WE STAND AND WHERE DO WE GO?
    Martinez, Manel
    ACTA PHYSICA POLONICA B, 2008, 39 (10): : 2787 - 2805
  • [25] The DO upgrade: where we are and where we are going
    Evans, HG
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2001, 462 (1-2): : 179 - 183
  • [26] Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
    Peng, Yan
    Yan, Hongxiang
    Mei, Wuxuan
    Zhang, Pengfei
    Zeng, Changchun
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (10) : 1378 - 1391
  • [27] Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
    Yan Peng
    Hongxiang Yan
    Wuxuan Mei
    Pengfei Zhang
    Changchun Zeng
    Current Treatment Options in Oncology, 2023, 24 : 1378 - 1391
  • [28] TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?
    Zattra, Edoardo
    Stan, Roxana
    Russo, Irene
    Lo Nigro, Alessandro
    Peserico, Andrea
    Alaibac, Mauro
    IMMUNOTHERAPY, 2013, 5 (08) : 791 - 794
  • [29] Molecular Analysis of Renal Allograft Biopsies: Where Do We Stand and Where Are We Going?
    Snijders, Malou L. H.
    Varol, Hilal
    van der Zwan, Marieke
    Becker, Jan U.
    Hesselink, Dennis A.
    Baan, Carla C.
    von der Thusen, Jan H.
    Clahsen-van Groningen, Marian C.
    TRANSPLANTATION, 2020, 104 (12) : 2478 - 2486
  • [30] Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
    Harari, Sergio
    Humbert, Marc
    Blasi, Francesco
    Collard, Harold R.
    Matucci-Cerinic, Marco
    Simonneau, Gerald
    Vancheri, Carlo
    Wells, Athol U.
    Cottin, Vincent
    EUROPEAN RESPIRATORY REVIEW, 2015, 24 (137): : 375 - 377
12345